tirzepatide approved for obesity enhances weight loss with sustained treatment but discontinuation leads to weight regain Breaking News: FDA Approves Tirzepatide

Learn how SGLT2 inhibitors interact with weight loss surgery in patients with diabetes

To help answer these and many others, I recently launched The GLP-1 Dietitian Hub, a growing community and newsletter dedicated to empowering dietitians with practical, up to date resources, relevant research, and a space to connect so we can navigate GLP-1 therapy with confidence

As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to incomeraising questions for both Medicaid and Medicare.

GIP receptor activation: Enhances insulin secretion in a glucose-dependent manner and may improve fat metabolism

Easy to Mix, Gentle on the Body: ULTRAGUT fiber powder dissolves quickly

Many patients who start semaglutide eventually consider switching to tirzepatide, a dual-action therapy targeting both GLP-1 and GIP pathways